The future of translational lung cancer research: from classical randomised controlled trials to innovative platform trials

J. Menis (Padova, Italy)

Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Menis (Padova, Italy). The future of translational lung cancer research: from classical randomised controlled trials to innovative platform trials. International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
New clinical research strategies in thoracic oncology: clinical trial design, adaptive, basket and umbrella trials, new end-points and new evaluations of response
Source: Eur Respir Rev 2014; 23: 367-378
Year: 2014



Helium-hyperoxia a novel treatment for optimizing pulmonary rehabilitation: a randomized controlled trial
Source: Eur Respir J 2007; 30: Suppl. 51, 327s
Year: 2007

Applicability of randomized controlled trials (RCTs) results to real-life patients in COPD
Source: International Congress 2017 – Management of COPD
Year: 2017


Systematic qualitative review of randomised trials conducted in nonsmall cell lung cancer with a noninferiority or equivalence design
Source: Eur Respir J 2015; 45: 511-524
Year: 2015



Evidence of efficacy for sequential combination therapy in recent randomized controlled trials (RCTs)
Source: International Congress 2014 – Combination therapy in pulmonary arterial hypertension (PAH): the evidence grows
Year: 2014



Noninvasive strategies in COVID-19: epistemology, randomised trials, guidelines, physiology
Source: Eur Respir J, 57 (2) 2004247; 10.1183/13993003.04247-2020
Year: 2021



A trial like ALIC4E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness?
Source: ERJ Open Res, 4 (2) 00046-2018; 10.1183/23120541.00046-2018
Year: 2018



Sequential screening for lung cancer in a high-risk group: randomised controlled trial
Source: Eur Respir J, 54 (4) 1900581; 10.1183/13993003.00581-2019
Year: 2019



Clinical effectiveness of self-management of asthma in general practice: a randomized controlled trial
Source: Eur Respir J 2001; 18: Suppl. 33, 518s
Year: 2001

A smart mHealth tool versus a paper action plan to support self-management of COPD exacerbations: a randomised controlled trial
Source: International Congress 2019 – M-health/e-health I
Year: 2019

Real world effects of COPD medications: a cohort study with validation against results from randomised controlled trials
Source: Eur Respir J, 57 (3) 2001586; 10.1183/13993003.01586-2020
Year: 2021



A self-management programme for COPD: a randomised controlled trial
Source: Eur Respir J 2014; 44: 1538-1547
Year: 2014



Web-based collaborative training of clinical reasoning: a randomized trial
Source: Annual Congress 2009 - E-learning in medical education
Year: 2009


Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017



Clinical effect on uncontrolled asthma using a novel digital automated self-management solution: a physician-blinded randomised controlled crossover trial
Source: Eur Respir J, 54 (5) 1900983; 10.1183/13993003.00983-2019
Year: 2019



Current clinical trials
Source: ERS Research Seminar 2017 – Immunotherapy: a new standard of care in thoracic malignancies?
Year: 2017


Randomised controlled trials and real-life studies: two answers for one question
Source: Eur Respir Rev, 27 (149) 180080; 10.1183/16000617.0080-2018
Year: 2018